Avricore Health (AVCRF) Shares Outstanding (Diluted Average) (2013 - 2025)

Avricore Health (AVCRF) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $72.6 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $72.6 million, up 1.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $72.6 million (up 1.15% YoY), and the FY2025 annual result was $72.5 million, down 1.06% from the prior year.
• Shares Outstanding (Diluted Average) declined to $72.6 million in Q4 2025 per AVCRF's latest filing, from $73.6 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $77.2 million in Q2 2024 and troughed at $71.8 million in Q4 2024.
• A 4-year average of $74.2 million and a median of $73.9 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) rose 4.11% in 2024, then retreated 5.32% in 2025.
• A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $72.1 million in 2022, then advanced by 1.44% to $73.1 million in 2023, then dropped by 1.81% to $71.8 million in 2024, then climbed by 1.15% to $72.6 million in 2025.
• Business Quant data shows AVCRF's Shares Outstanding (Diluted Average) at $72.6 million in Q4 2025, $73.6 million in Q3 2025, and $73.1 million in Q2 2025.